Picture of Cardlytics logo

CDLX Cardlytics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
TechnologySpeculativeMicro CapNeutral

Annual cashflow statement for Cardlytics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-129-465-135-189-103
Depreciation
Non-Cash Items66.938512217181.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital-6.7-11.3-13.5-15.85.71
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities-38.5-53.9-0.185-8.829.29
Capital Expenditures-12.6-13.5-12.4-19.3-15.8
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-494-2.272.330.5520.48
Acquisition of Business
Sale of Business
Cash from Investing Activities-507-15.8-10.1-18.7-15.3
Financing Cash Flow Items-0.39-0.331-50-20.4-5.12
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities486-40-201.44-11.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-59.8-112-30.2-26.2-16.9